van der Graaf Y - Search Results

1

Measuring and targeting aldosterone and renin in atherosclerosis-a review of clinical data.

Hillaert MA, Lentjes EG, Beygui F, Kemperman H, Asselbergs FW, Nathoe HM, Agostoni P, Voskuil M, Ivanes F, Jude B, Bertrand ME, Pasterkamp G, van der Graaf Y, Doevendans PA, Montalescot G, Van Belle E. Hillaert MA, et al. Among authors: van der graaf y, van belle e. Am Heart J. 2011 Oct;162(4):585-96. doi: 10.1016/j.ahj.2011.06.015. Epub 2011 Sep 9. Am Heart J. 2011. PMID: 21982648 Review.

2

Aldosterone, atherosclerosis and vascular events in patients with stable coronary artery disease.

Hillaert MA, Lentjes EG, Kemperman H, van der Graaf Y, Nathoe HM, Beygui F, Montalescot G, Doevendans PA, Wassink AM, van Belle E; SMART Study Group. Hillaert MA, et al. Among authors: van der graaf y, van belle e. Int J Cardiol. 2013 Sep 1;167(5):1929-35. doi: 10.1016/j.ijcard.2012.05.034. Epub 2012 Jun 23. Int J Cardiol. 2013. PMID: 22727970 Free article.

3

Gender difference in long-term prognosis among patients with cardiovascular disease.

van der Meer MG, Cramer MJ, van der Graaf Y, Doevendans PA, Nathoe HM; (on behalf of the SMART study group). van der Meer MG, et al. Among authors: van der graaf y. Eur J Prev Cardiol. 2014 Jan;21(1):81-9. doi: 10.1177/2047487312460519. Epub 2012 Sep 5. Eur J Prev Cardiol. 2014. PMID: 22952288

4

The impact of susceptibility loci for coronary artery disease on other vascular domains and recurrence risk.

Tragante V, Doevendans PA, Nathoe HM, van der Graaf Y, Spiering W, Algra A, de Borst GJ, de Bakker PI, Asselbergs FW; SMART study group. Tragante V, et al. Among authors: van der graaf y. Eur Heart J. 2013 Oct;34(37):2896-904. doi: 10.1093/eurheartj/eht222. Epub 2013 Jul 4. Eur Heart J. 2013. PMID: 23828831

5

The combined use of aspirin, a statin, and blood pressure-lowering agents (polypill components) and the risk of vascular morbidity and mortality in patients with coronary artery disease.

Lafeber M, Spiering W, van der Graaf Y, Nathoe H, Bots ML, Grobbee DE, Visseren FL. Lafeber M, et al. Among authors: van der graaf y. Am Heart J. 2013 Aug;166(2):282-289.e1. doi: 10.1016/j.ahj.2013.04.011. Epub 2013 Jun 15. Am Heart J. 2013. PMID: 23895811

6

Worse outcome in women with STEMI: a systematic review of prognostic studies.

van der Meer MG, Nathoe HM, van der Graaf Y, Doevendans PA, Appelman Y. van der Meer MG, et al. Among authors: van der graaf y. Eur J Clin Invest. 2015 Feb;45(2):226-35. doi: 10.1111/eci.12399. Eur J Clin Invest. 2015. PMID: 25556757 Review.

7

The relation between the presence of cardiovascular disease and vascular risk factors in offspring and the occurrence of new vascular events in their parents already at high vascular risk.

Weijmans M, van der Graaf Y, de Borst GJ, Asselbergs FW, Cramer MJ, Algra A, Visseren FL; SMART study group. Weijmans M, et al. Among authors: van der graaf y. Am Heart J. 2015 Oct;170(4):744-752.e2. doi: 10.1016/j.ahj.2015.06.023. Epub 2015 Jul 3. Am Heart J. 2015. PMID: 26386798

8

CETP genotype predicts increased mortality in statin-treated men with proven cardiovascular disease: an adverse pharmacogenetic interaction.

Regieli JJ, Jukema JW, Grobbee DE, Kastelein JJ, Kuivenhoven JA, Zwinderman AH, van der Graaf Y, Bots ML, Doevendans PA. Regieli JJ, et al. Among authors: van der graaf y. Eur Heart J. 2008 Nov;29(22):2792-9. doi: 10.1093/eurheartj/ehn465. Epub 2008 Oct 28. Eur Heart J. 2008. PMID: 18957472

9

The impact of polyvascular disease on long-term outcome in percutaneous coronary intervention patients.

van der Meer MG, Cramer MJ, van der Graaf Y, Appelman Y, Doevendans PA, Nathoe HM; SMART Study Group. van der Meer MG, et al. Among authors: van der graaf y. Eur J Clin Invest. 2014;44(3):231-9. doi: 10.1111/eci.12222. Epub 2013 Dec 27. Eur J Clin Invest. 2014. PMID: 24372467

10

Effect of statin therapy on incident type 2 diabetes mellitus in patients with clinically manifest vascular disease.

van de Woestijne AP, van der Graaf Y, Westerink J, Nathoe HM, Visseren FL. van de Woestijne AP, et al. Among authors: van der graaf y. Am J Cardiol. 2015 Feb 15;115(4):441-6. doi: 10.1016/j.amjcard.2014.11.021. Epub 2014 Nov 29. Am J Cardiol. 2015. PMID: 25554536

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

641 results

Search Page